Liquid Biopsies Poorly miRror Renal Ischemia-Reperfusion Injury

Adaysha C Williams1, Vaishali Singh2, Pengyuan Liu1

  • 1Department of Physiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

Non-Coding RNA
|April 27, 2023
PubMed

Insights

Early detection of acute kidney injury (AKI) is challenging. This study found limited overlap in microRNA (miRNA) biomarkers between rat kidney tissue and urine, suggesting a need for comprehensive analysis to identify reliable AKI diagnostics.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nephrology

Background:

  • Acute kidney injury (AKI) is a critical condition characterized by rapid renal function decline, often detected late.
  • Biofluid microRNAs (miRNAs) are investigated as potential biomarkers for AKI due to their regulatory roles in kidney pathophysiology.
  • Early and accurate detection of AKI remains a significant clinical challenge.

Purpose of the Study:

  • To investigate the overlap of microRNA (miRNA) profiles in the renal cortex, urine, and plasma of a rat model with ischemia-reperfusion (IR)-induced AKI.
  • To assess the potential of urinary and plasma miRNAs as non-invasive biomarkers for AKI.
  • To identify common and differentially expressed miRNAs across different sample types in AKI.

Main Methods:

  • Induction of bilateral renal ischemia in rats for 30 minutes, followed by reperfusion.
  • Collection of urine over 24 hours post-reperfusion.
  • Small RNA sequencing of renal cortex, urine, and plasma samples for miRNA profiling.

Main Results:

  • A strong correlation was observed in normalized miRNA abundance between urine and renal cortex samples, irrespective of injury status (R² = 0.8710 for IR, R² = 0.9716 for sham).
  • A limited number of miRNAs were differentially expressed across multiple sample types (renal cortex, urine, plasma).
  • No differentially expressed miRNAs with significant sequence conservation were found common to both renal cortex and urine samples.

Conclusions:

  • While urinary and renal cortex miRNA profiles show correlation, the limited overlap in differentially expressed miRNAs suggests challenges in using them as direct biomarkers for AKI.
  • Comprehensive analysis of pathological tissues and biofluids is crucial for identifying the cellular origin of altered miRNAs.
  • Further investigation at earlier time points is necessary to fully evaluate the clinical potential of miRNA biomarkers for AKI.